Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

OBJECTIVE: This study was undertaken to evaluate glucocorticoid dosages and serologic findings in patients with giant cell arteritis (GCA) flares. METHODS: Patients with GCA were randomly assigned to receive double‐blind dosing with either subcutaneous tocilizumab (TCZ) 162 mg weekly plus 26‐week pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, John H., Tuckwell, Katie, Dimonaco, Sophie, Klearman, Micki, Aringer, Martin, Blockmans, Daniel, Brouwer, Elisabeth, Cid, Maria C., Dasgupta, Bhaskar, Rech, Juergen, Salvarani, Carlo, Schulze‐Koops, Hendrik, Schett, Georg, Spiera, Robert, Unizony, Sebastian H., Collinson, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772126/
https://www.ncbi.nlm.nih.gov/pubmed/30835950
http://dx.doi.org/10.1002/art.40876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772126/
https://www.ncbi.nlm.nih.gov/pubmed/30835950
http://dx.doi.org/10.1002/art.40876

Ejemplares similares